New Warfarin PGx Study Will Test New Dosing Algorithms, Aim to Avoid Criticisms of Past Trials
April 14, 2010
New Warfarin PGx Study Will Test New Dosing Algorithms, Aim to Avoid Criticisms of Past Trials
The Genetics Informatics Trial of Warfarin will apply new PGx algorithms to investigate the utility of genetic testing in the orthopedic population.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Study Shows PGx-based Warfarin Dosing Algorithm Beats INR Alone, Even in Second Week of Treatment
March 14, 2012 / Pharmacogenomics Reporter - When Might Warfarin PGx Be Better Than Pradaxa? Stakeholders Weigh In
October 27, 2010 / Pharmacogenomics Reporter - CMS to Reimburse for Genetic Testing in Iverson's Warfarin PGx Study; Genmark to Provide Platform
July 28, 2010 / Pharmacogenomics Reporter - New Releases
April 14, 2010 / Pharmacogenomics Reporter - AutoGenomics Withdraws IPO for Second Time
February 18, 2013 / GenomeWeb Daily News